MD, FACS
Professor, Otolaryngology
Division Chief of Head and Neck Surgical Oncology, Department of Otolaryngology
Director, Transoral Surgery Program
Vice Chair of Inpatient Operations and Quality
Director, Head and Neck Oncology Fellowship
UNC-Chapel Hill
Clinical Research
Head & Neck Oncology Program
Area of Interest
Dr Hackman’s clinical interests focus on:
- The role of neoadjuvant risk adaptive therapy for head and neck cancer, and the role of transoral surgery (robotic and laser) to minimize functional impairment and maximize oncologic outcomes
- Salivary Gland diseases
- Simulation training for robotic surgery
He has addition research interests in the role of the microbiomes and tumor micro-environment on the formation of oral cancers and patient responses to therapy and outcomes, as well as the role of radiomics and genomics for therapy/treatment selection and prognostic implications.
Dr. Hackman has a passion for quality improvement, sitting on multiple hospital committees focusing perioperative patient risk reduction and steering a committee on physician excellence.
News and Stories
Radiation vs. chemo: how to decide what’s best
Trevor Hackman, MD, explains some of the common options for cancer treatment and what your doctor considers when making a recommendation.
Types and treatment of salivary gland cancer
UNC Lineberger’s Trevor G. Hackman, MD, a UNC Health head and neck cancer specialist, shares what you need to know about salivary gland cancer.
